comprehensive -WSS

comprehensive

author：explore 2025-09-28 00:47:40 - browse：6

Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC. — Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： UCLA team creates talking throat patch for voice disorders

entertainment

explore

WSS

UCLA team creates talking throat patch for voice disorders

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Amid AI frenzy, a top HHS official's quest to create safeguards

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Boston's new lab space is opening empty

explore

comprehensive

entertainment

Cancer drug shortages should be causing more outrage

Pushing for an NIH office for post

Drug repurposing or repositioning? The language matters

Novartis develops a rapidly manufactured CAR

Psychedelics group wrestles with new pharma identity

FDA advisers back CAR

The high cost of giving birth even with insurance

FDA advisers back CAR

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Inside the culture of fear in the White House science office of Eric Lander

explore

Medicare coverage of Wegovy, once blocked, now looks possible

Boston's new lab space is opening empty

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Where does female orgasm come from? Scientists think they know

What Henrietta Lacks's story taught me about my role as a doctor

Inside the culture of fear in the White House science office of Eric Lander

explore

Wikipedia

explore

hotspot